Value proposition

Advancing brain health. Transforming lives.

Lundbeck is a global pharmaceutical company solely focused on neuroscience. We cover the full value chain, from molecule to patient, in this rapidly evolving area of treatment.

For more than 70 years we have maintained our focus on neuroscience. Our legacy and commitment to breakthrough innovation provide the foundation for developing truly transformative treatments for neuro-rare and neuro-specialty conditions.

We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy.

Our curiosity, accountability, and adaptability enable us to advance brain health and transform lives. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination. We want to go faster and further on addressing the significant unmet needs of people living with brain disorders.

Neuroscience research, Schizophrenia, Psychosis, Parkinson's disease, Alzheimer's disease, Depression, Mental Health, Psychiatry, Neurology, Brain Health, Migraine, Brain Disease, Neuro-rare, and Neuro-speciality